EVONETIX
Company Snapshot
Founded: 2015
Entity Type: Private
Region: U.K.
Headquarter: Cambridge, U.K.
Key Geographics: U.K.
Corporate Address: 9a Coldham’s Business Park Norman Way Cambridge, CB1 3LH U.K. Tel: +44 -0-1223-930-300 www.evonetix.com
Company Overview
Evonetix, founded as a spinout from the University of Cambridge, is developing and commercializing technologies for low-cost, high-fidelity DNA synthesis. This technology is distinct from other next-generation synthesis methods by enabling the production of longer, highly accurate DNA strands at low cost. The main components of the synthesis technology include the use of silicon arrays, compatibility with both conventional chemicals and enzymatic DNA synthesis, and a high-fidelity assembly process. Producing high-quality DNA is important for synthetic biology and drug discovery applications. The company’s DNA synthesis solutions enable the design of precise cell-based screening assays to test drug responses.
EVONETIX In News
Company's Business Segments
- Products : mRNA Vaccines, Antibody Engineering, Others
- Services : Benchtop Gene Synthesis Platform, Others
Applications/End User Industries
- Healthcare
- Pharmaceuticals
- Biotechnology
- Research and Academics
- Life Science